Making SCLC Not So Small Anymore ~ Virtual Program ~ 3 OFFERINGSSocial Media CoordinatorMay 3, 20240 min readUS-ONC-2400010_DSE SCLC Specialty Series Invite_Nurse Info_vFINAL.pdfDownload PDF • 301KB
CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's
NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1
NEW EVENT! Make a Change in cGVHD Treatment Strategy and Provide Rapid, Durable Responses ~ March 19th, 2025 at Joe's on Newbury
Comments